These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 34049903)

  • 1. Association between vitamin D supplementation or serum vitamin D level and susceptibility to SARS-CoV-2 infection or COVID-19 including clinical course, morbidity and mortality outcomes? A systematic review.
    Grove A; Osokogu O; Al-Khudairy L; Mehrabian A; Zanganeh M; Brown A; Court R; Taylor-Phillips S; Uthman OA; McCarthy N; Kumar S; Clarke A
    BMJ Open; 2021 May; 11(5):e043737. PubMed ID: 34049903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D supplementation for the treatment of COVID-19: a living systematic review.
    Stroehlein JK; Wallqvist J; Iannizzi C; Mikolajewska A; Metzendorf MI; Benstoem C; Meybohm P; Becker M; Skoetz N; Stegemann M; Piechotta V
    Cochrane Database Syst Rev; 2021 May; 5(5):CD015043. PubMed ID: 34029377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
    Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The link between COVID-19 and VItamin D (VIVID): A systematic review and meta-analysis.
    Bassatne A; Basbous M; Chakhtoura M; El Zein O; Rahme M; El-Hajj Fuleihan G
    Metabolism; 2021 Jun; 119():154753. PubMed ID: 33774074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic anticoagulants for people hospitalised with COVID-19.
    Flumignan RL; Tinôco JDS; Pascoal PI; Areias LL; Cossi MS; Fernandes MI; Costa IK; Souza L; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013739. PubMed ID: 33502773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Dittrich S; Domen J; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013665. PubMed ID: 32633856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measures implemented in the school setting to contain the COVID-19 pandemic.
    Krishnaratne S; Littlecott H; Sell K; Burns J; Rabe JE; Stratil JM; Litwin T; Kreutz C; Coenen M; Geffert K; Boger AH; Movsisyan A; Kratzer S; Klinger C; Wabnitz K; Strahwald B; Verboom B; Rehfuess E; Biallas RL; Jung-Sievers C; Voss S; Pfadenhauer LM
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD015029. PubMed ID: 35037252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.
    Constantin AM; Noertjojo K; Sommer I; Pizarro AB; Persad E; Durao S; Nussbaumer-Streit B; McElvenny DM; Rhodes S; Martin C; Sampson O; Jørgensen KJ; Bruschettini M
    Cochrane Database Syst Rev; 2024 Apr; 4(4):CD015112. PubMed ID: 38597249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D supplementation for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials.
    Kümmel LS; Krumbein H; Fragkou PC; Hünerbein BL; Reiter R; Papathanasiou KA; Thölken C; Weiss ST; Renz H; Skevaki C
    Front Immunol; 2022; 13():1023903. PubMed ID: 36389703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and safety of vitamin D in relation to bone health.
    Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
    Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.
    Nussbaumer-Streit B; Mayr V; Dobrescu AI; Chapman A; Persad E; Klerings I; Wagner G; Siebert U; Ledinger D; Zachariah C; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013574. PubMed ID: 33959956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Vitamin D and Novel SARS-CoV-2 Respiratory Dysfunction - A Scoping Review of Current Evidence and Its Implication for COVID-19 Pandemic.
    Santaolalla A; Beckmann K; Kibaru J; Josephs D; Van Hemelrijck M; Irshad S
    Front Physiol; 2020; 11():564387. PubMed ID: 33324234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of routine laboratory tests to predict mortality and deterioration to severe or critical COVID-19 in people with SARS-CoV-2.
    De Rop L; Bos DA; Stegeman I; Holtman G; Ochodo EA; Spijker R; Otieno JA; Alkhlaileh F; Deeks JJ; Dinnes J; Van den Bruel A; McInnes MD; Leeflang MM; ; Verbakel JY
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD015050. PubMed ID: 39105481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low vitamin D levels do not aggravate COVID-19 risk or death, and vitamin D supplementation does not improve outcomes in hospitalized patients with COVID-19: a meta-analysis and GRADE assessment of cohort studies and RCTs.
    Chen J; Mei K; Xie L; Yuan P; Ma J; Yu P; Zhu W; Zheng C; Liu X
    Nutr J; 2021 Oct; 20(1):89. PubMed ID: 34719404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
    Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013587. PubMed ID: 33624299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ivermectin for preventing and treating COVID-19.
    Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do vitamin D levels or supplementation play A role in COVID-19 outcomes?-a narrative review.
    Shetty AJ; Banerjee M; Prasad TN; Bhadada SK; Pal R
    Ann Palliat Med; 2024 Jan; 13(1):162-177. PubMed ID: 38124476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of vitamin D and magnesium supplementation on clinical symptoms and serum inflammatory and oxidative stress markers in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
    Ramezani-Jolfaie N; Eftekhar E; Dadinasab M; Hesarooeyeh ZG; Pakdaman P; Razmpour F; Javedan G; Khayatian M; Azad MH; Davoodian P; Brahimi E; Rafati S; Nikoofal-Sahlabadi S; Mohammadi M
    Trials; 2023 Feb; 24(1):87. PubMed ID: 36747270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.